Trump’s DEA revolving door: Fourth Administrator in As Many Months Sounds Alarm Bells For Cannabis Industry MEDCAN24

Donald Trump gave the thumbs up to the fourth chief of the Drug Enforcement Administration, a position that has not been filled in DEA in six months. This is a worrying sign for cannabis use in the US.

Trump has now nominated Terrance C. Cole as the next DEA administrator, less than a month after appointing long-time cannabis sceptic Derek S. Maltz as ‘acting administrator.’

It’s still not known why Maltz’s replacement is a law enforcement veteran with 30 years of experience and a former DEA officer. This has caused more anxiety in the cannabis community.

Cole has historically taken an even more hardline stance than his all-too-temporary predecessor, publishing numerous public posts claiming, among other things, that cannabis is ‘four times more dangerous’ than 30 years ago, that it leads to higher suicide risk, while advocating a #justsayno stance.

Cole will still need to be confirmed before taking office by the Senate. Given his firm stance against cannabis and drugs, this could prove a difficult process. Upon confirmation, he would inherit the rescheduling, as well as the growing scrutiny of the DEA for delaying the administrative hearings.

One analyst said that this puts the process of rescheduling on an even more dangerous terrain. MEDCAN24 It could have much greater consequences on the cannabis policies in this country.

Deborah Tharp is a cannabis researcher and legal consultant. She says this lends credibility to the idea that the Administration wants to implement Project 2025 despite public opinion. This includes waging a war against state-legal marijuana.

Trump has prohibitionists who are hard-core in the right places. It’s now time to begin praying for miracles.

But she says that his decisions reveal a lack in cohesion, which is no surprise, considering the President’s propensity to shift his stances on major topics.

It has been shown in the choices he made for the DEA’s head. Matt Gaetz – Trump’s initial choice as administrator – announced his resignation in November, citing a House of Ethics Committee probe into sexual harassment.

After a few weeks, his next pick, Florida County sheriff Chad Chronister abruptly retracted his nomination.

Chronister’s abrupt departure was originally framed by Trump as an act of voluntary resignation, invoking his devotion to his constituency. But Trump sought to change this narrative to suit his own, declaring: “He never left.” He left because I was not happy with what he had said to his pastors or other supporters.

With suspicions that the far-right think tank, The Heritage Foundation, is largely guiding this administration, Tharp fears the US is ‘going to get very, very regressive’ in the coming months and years.

In the age of Trump however, the pace of change is accelerating and nothing can be guaranteed. Continued bipartisan support of cannabis reforms may prove to have a major impact on the market.

Donald Trump gave the thumbs up to the fourth chief of the Drug Enforcement Administration, a position that has not been filled in DEA in only a few months. This is a worrying sign for cannabis’ future in the US.

Trump has now nominated Terrance C. Cole as the next DEA administrator, less than a month after appointing long-time cannabis sceptic Derek S. Maltz as ‘acting administrator.’

Although it is not clear yet why Maltz has been shunned, the replacement of Maltz, a former DEA agent and 30-year veteran in law enforcement, has further frightened those who are involved with cannabis.

Cole has historically taken an even more hardline stance than his all-too-temporary predecessor, publishing numerous public posts claiming, among other things, that cannabis is ‘four times more dangerous’ than 30 years ago, that it leads to higher suicide risk, while advocating a #justsayno stance.

Cole still needs to be confirmed by Senate before he can take office. This could be a controversial process, given Cole’s hardline position on marijuana and drug enforcement. The rescheduling will be his to inherit, as well as the growing scrutiny of the DEA for delaying the administrative hearings.

One analyst said that this puts the process of rescheduling on an even more dangerous terrain. MEDCAN24 It could have much greater consequences on the cannabis policies in this country.

Deborah Tharp is a cannabis researcher and legal consultant. She says this lends credibility to the idea that the Administration wants to implement Project 2025 despite public opinion. This includes waging a war against state-legal marijuana.

Trump now has hard-core prohibitionists everywhere. It’s now time to begin praying for miracles.

But she says that his decisions reveal a lack in cohesion, which is no surprise, considering the President’s propensity to shift his stance on major topics at a moment’s notice.

It has been shown in the choices he made for the DEA’s head. Matt Gaetz, Trump’s first choice for administrator, said in November he would withdraw from the process while he handled a House of Ethics Committee inquiry into sexual misconduct.

Just weeks after his initial nomination, Florida County Sherriff Chad Chronister suddenly rescinded.

Chronister’s abrupt exit was first framed as voluntary, citing his dedication to constituents. However, Trump quickly sought to rectify this, to fit his narrative. He stated: “He did not pull out.” I removed him because I didn’t like what he told my pastors or other supporters.

With suspicions that the far-right think tank, The Heritage Foundation, is largely guiding this administration, Tharp fears the US is ‘going to get very, very regressive’ in the coming months and years.

In the age of Trump however, the pace of change is accelerating and nothing can be guaranteed. Continued bipartisan support of cannabis reforms may prove to have a major impact on the future of this market.

Cannabis Law Resources in Poland

Discover essential legal information about the cultivation of cannabis, its sale, and regulations governing medical products in Poland. These guides will help you understand the legal requirements, such as certifications and permissions.

• 
  Polish News Registration and Interests of Cannabis Businesses
  
• 
  Permissions for Cannabis Sales in Poland
  
• 
  Authorization for Importing or Manufacturing Medical Products
  
• 
  Permission for Manufacturing or Importing Medical Products
  
• 
  Certificate of Good Manufacturing Practices (GMP)
  
• 
  Registration of Medical Products in Poland